Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
VIVO similar filings
- 29 Jan 21 Departure of Directors or Certain Officers
- 12 Jan 21 Other Events
- 7 Jan 21 Meridian Bioscience Announces Better-than-expected Preliminary First Quarter Fiscal 2021 Revenue Results
- 30 Dec 20 Changes in Registrant's Certifying Accountant
- 13 Nov 20 Meridian Bioscience Reports Strong Fourth Quarter and Record Full-year Fiscal 2020 Operating Results and Provides Fiscal 2021 Guidance
- 10 Aug 20 Results of Operations and Financial Condition
- 7 Aug 20 Meridian Bioscience Reports Fiscal Third Quarter 2020 Operating Results – Best Quarter In Company History – Raises Full Year Guidance
Filing view
External links
Exhibit 16.1
December 28, 2020
U.S. Securities and Exchange Commission
Office of the Chief Accountant
100 F Street, NE
Washington, DC 20549
Re: Meridian Bioscience, Inc.
File No. 0-14902
Dear Sir or Madam:
We have read Item 4.01 of Form 8-K of Meridian Bioscience, Inc. dated December 22, 2020, and agree with the statements concerning our Firm contained therein.
Very truly yours,
/s/ GRANT THORNTON LLP